Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Projected 2024 revenue for top drugs approved U.S. 2018

This statistic displays the projected 2022 revenue for selected top drugs approved in the U.S. in 2018. Biktarvy, developed by Gilead Sciences, is estimated to generate some five billion U.S. dollars in annual revenue in 2024.

Projected 2024 revenue for selected top drugs approved in the U.S. in 2018

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

February 2019

Region

United States

Survey time period

as of January 2019

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "U.S. pharmaceutical industry"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.